Why a drug treatment for dementia has eluded us

Pfizer has announced it will stop research into developing drugs to treat Alzheimer’s disease, after costly failed attempts over the past decade Jürgen Götz, Director, Clem Jones Centre for Ageing Dementia Research, The University of Queensland Finding a cure for neurodegenerative diseases such as Alzheimer’s is challenging. They’re difficult to diagnose, and drugs struggle to get